Logo Logo

Publications by Ringden, O.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Jump to: 2018 | 2016 | 2004
Number of items: 3.


Ringden, O.; Labopi, M.; Sadeghi, B.; Mailhol, A.; Beelen, D.; Floisand, Y.; Ghavamzadeh, A.; Finke, J.; Ehninger, G.; Volin, L.; Socie, G.; Kröger, N.; Stuhler, G.; Ganser, A.; Schmid, C.; Giebel, S.; Mohty, M.; Nagler, A. (2018): What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease? In: Journal of Internal Medicine, Vol. 283, No. 2: pp. 166-177


Ringden, O.; Labopin, M.; Schmid, C.; Sadeghi, B.; Polge, E.; Tischer, J.; Ganser, A.; Michallet, M.; Kanz, L.; Schwerdtfeger, R.; Nagler, A.; Mohty, M. (2016): Sequential chemotherapy followed by reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukemia (AML): a survey from the Acute Leukemia Working Party of EBMT. In: Bone Marrow Transplantation, Vol. 51: S476-S477


Schmid, C.; Schleuning, M.; Aschan, J.; Ringden, O.; Hahn, J.; Holler, E.; Hegenbart, U.; Niederwieser, D. W.; Dugas, Martin; Ledderose, G.; Kolb, H. J. (2004): Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation [2]. In: Leukemia, Vol. 18, No. 8: pp. 1430-1433

This list was generated on Tue Jul 14 01:08:24 2020 CEST.